These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell. Undem BJ; Peachell PT; Lichtenstein LM J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368 [TBL] [Abstract][Full Text] [Related]
3. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. Patella V; Marinò I; Lampärter B; Arbustini E; Adt M; Marone G J Immunol; 1995 Mar; 154(6):2855-65. PubMed ID: 7533185 [TBL] [Abstract][Full Text] [Related]
4. Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis. Kiener HP; Baghestanian M; Dominkus M; Walchshofer S; Ghannadan M; Willheim M; Sillaber C; Graninger WB; Smolen JS; Valent P Arthritis Rheum; 1998 Feb; 41(2):233-45. PubMed ID: 9485081 [TBL] [Abstract][Full Text] [Related]
5. Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine. Gruber B; Poznansky M; Boss E; Partin J; Gorevic P; Kaplan AP Arthritis Rheum; 1986 Aug; 29(8):944-55. PubMed ID: 2427092 [TBL] [Abstract][Full Text] [Related]
6. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2. Levi-Schaffer F; Dayton ET; Austen KF; Hein A; Caulfield JP; Gravallese PM; Liu FT; Stevens RL J Immunol; 1987 Nov; 139(10):3431-41. PubMed ID: 2445814 [TBL] [Abstract][Full Text] [Related]
8. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells. Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the anti-inflammatory effect of FK-506 on human mast cells. de Paulis A; Cirillo R; Ciccarelli A; de Crescenzo G; Oriente A; Marone G J Immunol; 1991 Dec; 147(12):4278-85. PubMed ID: 1721644 [TBL] [Abstract][Full Text] [Related]
10. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. Holgate ST; Burns GB; Robinson C; Church MK J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153 [TBL] [Abstract][Full Text] [Related]
11. Co-culture of human lung-derived mast cells with mouse 3T3 fibroblasts: morphology and IgE-mediated release of histamine, prostaglandin D2, and leukotrienes. Levi-Schaffer F; Austen KF; Caulfield JP; Hein A; Gravallese PM; Stevens RL J Immunol; 1987 Jul; 139(2):494-500. PubMed ID: 2439587 [TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of human intestinal mucosal mast cells. Fox CC; Dvorak AM; Peters SP; Kagey-Sobotka A; Lichtenstein LM J Immunol; 1985 Jul; 135(1):483-91. PubMed ID: 2582045 [TBL] [Abstract][Full Text] [Related]
13. A lavage method for dynamic intraarticular monitoring of animal joints in situ: quantification and release kinetics of histamine after selective synovial mast cell activation by diverse secretagogues. Malone DG; Verbsky JW; Dolan PW J Lab Clin Med; 1991 Sep; 118(3):269-79. PubMed ID: 1717621 [TBL] [Abstract][Full Text] [Related]
14. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells. Wells E; Jackson CG; Harper ST; Mann J; Eady RP J Immunol; 1986 Dec; 137(12):3941-5. PubMed ID: 2431049 [TBL] [Abstract][Full Text] [Related]
15. Mast cell activation in human synovium explants by calcium ionophore A23187, compound 48/80, and rabbit IgG anti-human IgE, but not morphine sulfate. Verbsky JW; McAllister PK; Malone DG Inflamm Res; 1996 Jan; 45(1):35-41. PubMed ID: 8821777 [TBL] [Abstract][Full Text] [Related]
16. Mucosal mast cells. II. Effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells. Pearce FL; Befus AD; Gauldie J; Bienenstock J J Immunol; 1982 Jun; 128(6):2481-6. PubMed ID: 6176639 [TBL] [Abstract][Full Text] [Related]
18. The histologic and functional characterization of enzymatically dispersed intestinal mast cells of nonhuman primates: effects of secretagogues and anti-allergic drugs on histamine secretion. Barrett KE; Metcalfe DD J Immunol; 1985 Sep; 135(3):2020-6. PubMed ID: 2410511 [TBL] [Abstract][Full Text] [Related]
19. Characterization of primate bronchoalveolar mast cells. I. IgE-dependent release of histamine, leukotrienes, and prostaglandins. Wells E; Harper ST; Jackson CG; Mann J; Eady RP J Immunol; 1986 Dec; 137(12):3933-40. PubMed ID: 2431048 [TBL] [Abstract][Full Text] [Related]
20. The secretory characteristics of mast cells isolated from the human large intestinal mucosa and muscle. Rees PH; Hillier K; Church MK Immunology; 1988 Nov; 65(3):437-42. PubMed ID: 2463223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]